Mesirow Financial Investment Management, Inc. Gilead Sciences, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.84 Billion
- Q2 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 7,362 shares of GILD stock, worth $886,900. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,362
Previous 7,434
0.97%
Holding current value
$886,900
Previous $832,000
1.92%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,342Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.13 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.58 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.52 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $151B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...